体外膜肺氧合在院内成人心源性休克和心脏骤停中的应用研究
隋明亮, 汤卫兵, 吴长江, 黄超发, 杨雅迪, 夏大梅

Application of extracorporeal membrane oxygenation to adults with cardiogenic shock and cardiac arrest in hospital
SUI Mingliang, TANG Weibing, WU Changjiang, HUANG Chaofa, YANG Yadi, XIA Damei
表 1 入组患者的一般人口学资料、临床资料及SOFA评分分析
Tab 1 Analysis of general demographic data, clinical data and SOFA scores of enrolled patients
ItemTotal (n=19)E-CS group (n=10)ECPR group (n=9)
Age/year46.5 (34.5, 61.6)50.8 (37.2, 63.5)43.6 (31.6, 59.8)
Male/n(%)15 (78.9)8 (80.0)7 (77.8)
BMI/(kg·m-2)22.3±2.422.5±2.822.1±1.9
Previous underlying diseases/n(%)
Diabetes4 (21.1)2 (20.0)2 (22.2)
Hypertension5 (26.3)4 (40.0)1 (11.1)
Hyperlipidemia2 (10.5)1 (10.0)1 (11.1)
Chronic heart failure3 (15.8)1 (10.0)2 (22.2)
Coronary artery disease6 (31.6)5 (50.0)1 (11.1)
Chronic kidney disease3 (15.8)2 (20.0)1 (11.1)
Etiology of CS and CA/n(%)
Acute myocardial infarction8 (42.2)4 (40.0)4 (44.4)
Acute severe myocarditis3 (15.8)1 (10.0)2 (22.2)
Heart failure7 (36.8)4 (40.0)3 (33.3)
Cardiomyopathy1 (5.3)1 (10.0)0 (0)
Combined IABP treatment/n(%)6 (31.6)2 (20.0)4 (44.4)
ECMO tube placement time/min33.8 (25.5, 44.3)38.5 (27.8, 48.2)31.5 (25.3, 42.9)
D to I time/min79.5 (45.8, 98.2)86.5 (51.3, 116.2)76.7 (43.5, 96.9)
Before ECMO initiation
Lactic acid level/(mmol·L-1)10.7±4.010.2±4.911.1±2.8
AKI/n(%)11 (57.9)7 (70.0)2 (22.2)
CRRT/n(%)6 (31.6)4 (40.0)2 (22.2)
Ventilator support/n(%)16 (84.2)9 (90.0)9 (100.0)
24 h LCR after ECMO initiation/%67.0 (58.2, 76.3)63.6 (49.7, 74.6)69.2 (57.5, 83.4)
Duration of VA-ECMO/d4.0 (2.0, 6.8)3.9 (2.5, 5.8)4.5 (2.6, 6.5)
ECMO withdrawal success rate/n(%)12 (63.2)7 (70.0)5 (55.6)
Intensive care duration/d11.5 (5.8, 26.2)10.2 (3.8, 24.5)11.8 (4.1, 28.0)
Hospital mortality/n(%)12 (63.2)7 (70.0)5 (55.6)
DDCEW/n(%)5 (26.3)4 (40.0)1 (11.1)
SOFA scores/score14.2±3.713.8±4.514.8±4.5